Cargando…

Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally. Although several rapid commercial serological assays have been developed, little is known about their performance and accuracy in detecting SARS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashem, Anwar M., Alhabbab, Rowa Y., Algaissi, Abdullah, Alfaleh, Mohamed A., Hala, Sharif, Abujamel, Turki S., ElAssouli, M-Zaki, AL-Somali, Afrah A., Alofi, Fadwa S., Khogeer, Asim A., Alkayyal, Almohanad A., Mahmoud, Ahmad Bakur, Almontashiri, Naif A. M., Pain, Arnab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767212/ https://www.ncbi.nlm.nih.gov/pubmed/33352788 http://dx.doi.org/10.3390/pathogens9121067

Ejemplares similares

SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients
por: Algaissi, Abdullah, et al.
Publicado: (2020)

Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
por: Hashem, Anwar M., et al.
Publicado: (2020)

Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice
por: Alamri, Sawsan S., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia
por: Alhabbab, Rowa Y., et al.
Publicado: (2021)

Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay
por: Almahboub, Sarah A., et al.
Publicado: (2020)

Amplifying Lateral Flow Assay Signals for Rapid Detection of COVID‐19 Specific Antibodies
por: Alhabbab, Rowa Y., et al.
Publicado: (2022)

Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
por: Shuaib, Muhammad, et al.
Publicado: (2023)

A Robust, Safe, and Scalable Magnetic Nanoparticle Workflow for RNA Extraction of Pathogens from Clinical and Wastewater Samples
por: Ramos‐Mandujano, Gerardo, et al.
Publicado: (2021)

A Robust, Safe, and Scalable Magnetic Nanoparticle Workflow for RNA Extraction of Pathogens from Clinical and Wastewater Samples (Global Challenges 4/2021)
por: Ramos‐Mandujano, Gerardo, et al.
Publicado: (2021)

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
por: Alfaleh, Mohamed A., et al.
Publicado: (2020)

Simultaneous detection and mutation surveillance of SARS-CoV-2 and multiple respiratory viruses by rapid field-deployable sequencing
por: Bi, Chongwei, et al.
Publicado: (2021)

iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2
por: Ali, Zahir, et al.
Publicado: (2020)

Quick and Easy Assembly of a One-Step qRT-PCR Kit for COVID-19 Diagnostics Using In-House Enzymes
por: Takahashi, Masateru, et al.
Publicado: (2021)

Construction of VSVΔ51M oncolytic virus expressing human interleukin-12
por: Abdulal, Rwaa H., et al.
Publicado: (2023)

The importance of combining serological testing with RT-PCR assays for efficient detection of COVID-19 and higher diagnostic accuracy
por: Alamri, Sawsan S., et al.
Publicado: (2023)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Iron Chelation Reduces DNA Damage in Sickle Cell Anemia
por: Al-Khateeb, Rawan S., et al.
Publicado: (2021)

Apigenin Loaded Lipoid–PLGA–TPGS Nanoparticles for Colon Cancer Therapy: Characterization, Sustained Release, Cytotoxicity, and Apoptosis Pathways
por: Alfaleh, Mohamed A., et al.
Publicado: (2022)

Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
por: Alluhaybi, Khalid A., et al.
Publicado: (2021)

Genotoxicity of Air Borne Particulates Assessed by Comet and the Salmonella Mutagenicity Test in Jeddah, Saudi Arabia
por: ElAssouli, Sufian M., et al.
Publicado: (2007)

Mouth rinses efficacy on salivary SARS‐CoV‐2 viral load: A randomized clinical trial
por: Alzahrani, Manar M., et al.
Publicado: (2022)

SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
por: Alkayyal, Almohanad A., et al.
Publicado: (2023)

SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load
por: Mourier, Tobias, et al.
Publicado: (2022)

The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections
por: Sajini, Abdulrahim A., et al.
Publicado: (2021)

Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
por: Alhabbab, Rowa Y.
Publicado: (2020)

Lateral Flow Immunoassays for Detecting Viral Infectious Antigens and Antibodies
por: Alhabbab, Rowa Y.
Publicado: (2022)

Economical and Easily Obtainable Tools to Manually Develop Lateral Flow Immunoassay Strips
por: Alhabbab, Rowa Y.
Publicado: (2023)

The 9p21.3 risk locus for coronary artery disease: A 10-year search for its mechanism
por: Almontashiri, Naif A.M.
Publicado: (2017)

Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review
por: Moglan, Abdulaziz Molham, et al.
Publicado: (2023)

Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
por: Algaissi, Abdullah A., et al.
Publicado: (2020)

Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review
por: Hashem, Anwar M., et al.
Publicado: (2020)

Evaluating the therapeutic efficacy, tolerability, and safety of an aqueous extract of Costus speciosus rhizome in acute pharyngitis and acute tonsillitis: A pilot study
por: Bakhsh, Zainab A., et al.
Publicado: (2015)

Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016
por: Degnah, Afnan A., et al.
Publicado: (2020)

Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs
por: St-Cyr, Guillaume, et al.
Publicado: (2023)

Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine
por: Alkayyal, Almohanad A., et al.
Publicado: (2023)

Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay
por: Algaissi, Abdullah, et al.
Publicado: (2019)

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
por: Al-amri, Sawsan S., et al.
Publicado: (2017)

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer
por: Niavarani, Seyedeh-Raheleh, et al.
Publicado: (2023)

Livelihood activities, human mobility, and risk of malaria infection in elimination settings: a case–control study
por: Abdalal, Shaymaa A., et al.
Publicado: (2023)

Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma
por: Mansouri, Sarah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1mgu92lh48r7ndq0os15p7f8f0